RecruitingNCT06276309
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Studying Neuroendocrine neoplasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fujian Maternity and Child Health Hospital
- Principal Investigator
- Pengming Sun, PhDFujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University
- Enrollment
- 300 enrolled
- Eligibility
- FEMALE
- Timeline
- 2024 – 2025
Study locations (9)
- Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China
- Fujian Provincial Hospital, Fuzhou, Fujian, China
- Ningde Mindong Hospital, Ningde, Fujian, China
- Putian City first Hospital, Putian, Fujian, China
- The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China
- Zhangzhou affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China
- Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China
- Xiangya Hospital, Central South University, Changsha, Hunan, China
- Jiangxi maternal and Child Health Hospital, Nanchang, Jiangxi, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06276309 on ClinicalTrials.govOther trials for Neuroendocrine neoplasm
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06202066Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine CarcinomasRoswell Park Cancer Institute
- RECRUITINGNCT06282016Risk Factors for Neuroendocrine NeoplasmsBavarian Cancer Registry
- RECRUITINGPHASE2NCT07077551NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm TrialSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE3NCT05918302Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.Grupo Espanol de Tumores Neuroendocrinos
- RECRUITINGNCT06402695Observational Study on GEP-and Pulm-NET Treated at FPGFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGPHASE2NCT05879055A Study of PM8002 in Combination With Chemotherapy in Patients With NENBiotheus Inc.
- RECRUITINGNCT06337760YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.European Institute of Oncology
- RECRUITINGNANCT06523582Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsUniversidad Nacional Autonoma de Mexico